Minnesota SF4485 establishes a regulated psilocybin therapeutic use program for individuals aged 21 and older with qualifying medical conditions.
Minnesota SF4485 establishes a psilocybin therapeutic use program to allow individuals aged 21 and older with qualifying medical conditions to use psilocybin under supervision. The bill specifies the qualifying conditions, establishes a registration process for patients and facilitators, and sets rules for the cultivation, possession, and use of psilocybin. It also creates an advisory committee to advise the commissioner on the program and mandates public education and training programs for first responders.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.